These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16773205

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Activation of mitogen-activated protein kinase pathway by the antiandrogen hydroxyflutamide in androgen receptor-negative prostate cancer cells.
    Lee YF, Lin WJ, Huang J, Messing EM, Chan FL, Wilding G, Chang C.
    Cancer Res; 2002 Nov 01; 62(21):6039-44. PubMed ID: 12414626
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
    Recchia AG, Musti AM, Lanzino M, Panno ML, Turano E, Zumpano R, Belfiore A, Andò S, Maggiolini M.
    Int J Biochem Cell Biol; 2009 Mar 01; 41(3):603-14. PubMed ID: 18692155
    [Abstract] [Full Text] [Related]

  • 6. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
    Mukherjee B, Mayer D.
    Int J Oncol; 2008 Sep 01; 33(3):623-9. PubMed ID: 18695894
    [Abstract] [Full Text] [Related]

  • 7. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y, Li X, Jiang J, Frank SJ.
    Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991
    [Abstract] [Full Text] [Related]

  • 8. The phosphatidylinositol 3'-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells.
    Lin J, Adam RM, Santiestevan E, Freeman MR.
    Cancer Res; 1999 Jun 15; 59(12):2891-7. PubMed ID: 10383151
    [Abstract] [Full Text] [Related]

  • 9. Effect of leuprorelin acetate on cell growth and prostate-specific antigen gene expression in human prostatic cancer cells.
    Sica G, Iacopino F, Settesoldi D, Zelano G.
    Eur Urol; 1999 Jun 15; 35 Suppl 1():2-8. PubMed ID: 10081696
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Leuprorelin acetate affects adhesion molecule expression in human prostate cancer cells.
    Angelucci C, Lama G, Iacopino F, Sica G.
    Int J Oncol; 2011 Jun 15; 38(6):1501-9. PubMed ID: 21479359
    [Abstract] [Full Text] [Related]

  • 12. Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K.
    Gutiérrez-Cañas I, Juarranz MG, Collado B, Rodríguez-Henche N, Chiloeches A, Prieto JC, Carmena MJ.
    Prostate; 2005 Apr 01; 63(1):44-55. PubMed ID: 15468165
    [Abstract] [Full Text] [Related]

  • 13. Calcium-sensing receptor activation stimulates parathyroid hormone-related protein secretion in prostate cancer cells: role of epidermal growth factor receptor transactivation.
    Yano S, Macleod RJ, Chattopadhyay N, Tfelt-Hansen J, Kifor O, Butters RR, Brown EM.
    Bone; 2004 Sep 01; 35(3):664-72. PubMed ID: 15336602
    [Abstract] [Full Text] [Related]

  • 14. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH, Song YC, Kim SH, Jo H, Song YS.
    Ann N Y Acad Sci; 2009 Aug 01; 1171():642-8. PubMed ID: 19723115
    [Abstract] [Full Text] [Related]

  • 15. Regulation of prostate-specific antigen gene expression by an LH-RH analogue in human prostatic cells.
    Sica G, Zelano G, Settesoldi D, Iacopino F.
    Anticancer Res; 2003 Aug 01; 23(2B):1283-7. PubMed ID: 12820384
    [Abstract] [Full Text] [Related]

  • 16. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.
    Shah BH, Neithardt A, Chu DB, Shah FB, Catt KJ.
    J Cell Physiol; 2006 Jan 01; 206(1):47-57. PubMed ID: 15920762
    [Abstract] [Full Text] [Related]

  • 17. Dexamethasone suppresses DU145 cell proliferation and cell cycle through inhibition of the extracellular signal-regulated kinase 1/2 pathway and cyclin D1 expression.
    Gao QZ, Lu JJ, Liu ZD, Zhang H, Wang SM, Xu H.
    Asian J Androl; 2008 Jul 01; 10(4):635-41. PubMed ID: 18097517
    [Abstract] [Full Text] [Related]

  • 18. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
    Siu SW, Lau KW, Tam PC, Shiu SY.
    Prostate; 2002 Jul 01; 52(2):106-22. PubMed ID: 12111702
    [Abstract] [Full Text] [Related]

  • 19. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate.
    Santos SD, Verveer PJ, Bastiaens PI.
    Nat Cell Biol; 2007 Mar 01; 9(3):324-30. PubMed ID: 17310240
    [Abstract] [Full Text] [Related]

  • 20. Phosphatase-mediated crosstalk control of ERK and p38 MAPK signaling in corneal epithelial cells.
    Wang Z, Yang H, Tachado SD, Capó-Aponte JE, Bildin VN, Koziel H, Reinach PS.
    Invest Ophthalmol Vis Sci; 2006 Dec 01; 47(12):5267-75. PubMed ID: 17122112
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.